Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Detection of pepsin in sputum: a rapid and objective measure of airways reflux

Vicki Strugala, Andrew D. Woodcock, Peter W. Dettmar, Shoaib Faruqi, Alyn H. Morice
European Respiratory Journal 2016 47: 339-341; DOI: 10.1183/13993003.00827-2015
Vicki Strugala
1RD Biomed Ltd, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D. Woodcock
1RD Biomed Ltd, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter W. Dettmar
1RD Biomed Ltd, Castle Hill Hospital, Cottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shoaib Faruqi
2Centre for Cardiovascular and Metabolic Research, Hull York Medical School, University of Hull, Castle Hill Hospital, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alyn H. Morice
2Centre for Cardiovascular and Metabolic Research, Hull York Medical School, University of Hull, Castle Hill Hospital, Hull, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.h.morice@hull.ac.uk
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Detection of salivary pepsin (Peptest) may be a useful adjunct in the diagnosis of airway reflux http://ow.ly/T7B0l

To the Editor:

The diagnostic test, Peptest (RD Biomed Ltd, Cottingham, UK), detects pepsin in expectorated saliva and is established as a simple, noninvasive measure of reflux of gastric contents. It has been used to detect pepsin A in patients with both gastro-oesophageal reflux disease (GORD) and extra-oesophageal reflux into the laryngopharynx and airways [1–5].

Reflux has a substantial, but as yet undefined, component in the aetiology of cough hypersensitivity syndrome [6]. Currently evaluation is by the subjective Hull Airways Reflux Questionnaire (HARQ) [7] or objective, but costly and invasive, measures such as 24-h pH-metry, impedance [8], and high resolution manometry [8, 9]. These current diagnostic pathways have their limitations in detecting low levels of airways reflux that may be sufficient to cause chronic cough. We hypothesised that Peptest could provide simple objective confirmation of airways reflux in unselected patients with chronic cough.

Peptest was used in routine clinical practice in out-patients attending the Hull Cough Clinic at Castle Hill Hospital (Hull, UK), a secondary and tertiary referral centre. Verbal consent was obtained at the time of attendance. Chronic cough was defined as cough lasting >8 weeks.

Patients were instructed to provide three expectorated saliva/sputum samples into sample collection tubes (containing 0.01M citric acid) during daily activities and immediately after three spontaneous coughing episodes. Sample collection was optimised by providing patient leaflets and a video. The presence and concentration of pepsin was measured using Peptest by trained analysts and with a lateral flow-test reader calibrated with known concentrations of pepsin A standard. The lower limit of detection is 16 ng·mL−1 and upper limit of quantification was 500 ng·mL−1. Peptest is specific for pepsin A (isoforms 1, 3a, 3b and 3c) and does not detect pepsin C/Gastricsin (isoform 5) putatively suggested to be expressed in the lungs [10, 11]. As pepsin concentrations do not follow a normal distribution a non-parametric statistical analysis was performed.

We have tested 93 (55 female) chronic cough patients mean±sd age 58.4±13.8 years between August 2014 and December 2014. Smoking status was: smoker n=5, nonsmoker n=55, ex-smoker n=24 and unknown n=9. The mean±sd HARQ score (upper limit of normal 13) was 31.9±13.1 and cough duration was 5.6±7.0 years. Over a period of 4 months the 93 patients provided 262 evaluable samples for testing. 80 patients had at least one pepsin positive sample (86.0%). Pepsin concentrations ranged from 0 to 500 ng·mL−1 with a median (interquartile range (IQR)) of 31 ng·mL−1 (0–113.5) ng·mL−1.

We previously [1] used a similar triple sampling strategy in a thoroughly investigated normal asymptomatic healthy volunteer population. The absence of gastro-oesophageal reflux was confirmed by pH-impedance testing. In contrast to this chronic cough study these control samples were provided first thing in the morning, 1 h after lunch and 1 h after the evening meal. Of the 87 control subjects only 33 were found to have at least one positive sample (37.9%) but the pepsin concentration in those that were Peptest positive was very low, median (IQR) of 0 (0–0) ng·mL−1 pepsin, which represents physiological reflux.

Patients with chronic cough in our study had significantly increased prevalence of pepsin detection (p<0.0001 Fisher's exact test; 86% versus 38%) and increased pepsin concentration (p<0.0001 Mann–Whitney U-test, 31 ng·mL−1 versus 0 ng·mL−1) compared to the control group. There was a significant receiver operating characteristic (ROC) curve (0.7244, p<0.0001 area under the ROC curve) for chronic cough patients against the control population (figure 1a).

FIGURE 1
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1

a) Receiver operating characteristics curve for pepsin concentration measured in 93 chronic cough patients (262 samples) measured using Peptest (RD Biomed Ltd, Cottingham, UK). b) The mean (95% CI) pepsin concentration (measured using Peptest) of 93 chronic cough patients and 59 gastro-oesophageal reflux disease (GORD) patients providing samples within 15 min of a symptomatic episode [12] compared to 87 healthy controls [1].

Other primary lung pathology, such as COPD or IPF, was present in only 6% of the patients and did not influence the rate of pepsin detection (prevalence 83% with lung pathology versus 86% without lung pathology).

Interestingly, the mean pepsin concentration in this chronic cough population is comparable to the mean pepsin concentration seen in 59 symptomatic GORD patients [12] at the time of symptomatic episodes, as was the prevalence of pepsin detection (80%). Thus suggesting that the level of pepsin associated reflux seen in chronic cough patients may be pathologically relevant (figure 1b).

Acid suppression medication, usually proton pump inhibitors (PPI), had been prescribed to 30% of the patients at presentation. Acid suppression did not impact on the detection or concentration of refluxed pepsin (81%, 37 ng·mL−1 on PPI versus 89%, 28.5 ng·mL−1 off PPI; p>0.05 Fisher's exact test). We have previously shown in a randomised double-blind placebo-controlled study of esomeprazole [13] that acid suppression is of no significant benefit in the treatment of airways reflux associated chronic cough. For a patient with airway hypersensitivity a small amount of reflux (usually non-acid) may be sufficient to induce cough [14] and a pro-motility medical strategy (e.g. baclofen, metaclopramide or azithromycin) should be considered.

This prospective cohort study in a real-life setting has demonstrated Peptest has a high sensitivity to detect pepsin in the overwhelming majority of chronic cough patients during symptomatic episodes. Since some reflux is physiological a lack of specificity must be considered. In conjunction with subjective assessment this assay may aid in diagnosis, leading to more appropriate management strategies in chronic cough.

Acknowledgements

We gratefully acknowledge the RD Biomed Ltd technical assistance of Jeanine Fisher (Cottingham, UK), the NHS patient management of Karen Welburn and the NHS secretarial assistance of Hanka Remblance (both Centre for Cardiovascular and Metabloic Research, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham).

Footnotes

  • Support statement: This project was funded in part by the European Union through the Yorkshire Innovation Fund, under the Yorkshire and Humber European Regional Development Fund Programme 2007–2013.

  • Conflict of interest: Disclosures can be found alongside the online version of this article at erj.ersjournals.com

  • Received May 26, 2015.
  • Accepted September 11, 2015.
  • Copyright ©ERS 2016

References

  1. ↵
    1. Hayat JO,
    2. Gabieta-Somnez S,
    3. Yazaki E, et al.
    Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut 2015; 64: 373–380.
    OpenUrlAbstract/FREE Full Text
    1. Hayat JO,
    2. Yazaki E,
    3. Moore AT, et al.
    Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation. J Clin Gastroenterol 2014; 48: 318–327.
    OpenUrlCrossRefPubMed
    1. Ocak E,
    2. Kubat G,
    3. Yorulmaz I
    . Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux. Balkan Med J 2015; 32: 46–50.
    OpenUrlCrossRefPubMed
    1. de Bortoli N,
    2. Savarino E,
    3. Furnari M, et al.
    Use of a non-invasive pepsin diagnostic test to detect GERD: correlation with MII-ph evaluation in a series of suspected NERD patients. A pilot study. Gastroenterology 2013; 144: S118.
    OpenUrl
  2. ↵
    1. Savarino E,
    2. Carbone R,
    3. Marabotto E, et al.
    Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J 2013; 42: 1322–1331.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Morice AH
    . Chronic cough hypersensitivity syndrome. Cough 2013; 9: 14.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Morice AH,
    2. Faruqi S,
    3. Wright CE, et al.
    Cough hypersensitivity syndrome: a distinct entity. Lung 2011; 189: 73–79.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Everett CF,
    2. Morice AH
    . Gastroesophageal reflux and chronic cough. Minerva Gastroenterol Dietol 2004; 50: 205–213.
    OpenUrlPubMed
  6. ↵
    1. Vardar R,
    2. Sweis R,
    3. Anggiansah A, et al.
    Upper esophageal sphincter and esophageal motility in patients with chronic cough and reflux: assessment by high-resolution manometry. Dis Esophagus 2013; 26: 219–225.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Bohman JK,
    2. Kor DJ,
    3. Kashyap R, et al.
    Airway pepsin levels in otherwise healthy surgical patients receiving general anesthesia with endotracheal intubation. Chest 2013; 143: 1407–1413.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Elabiad MT,
    2. Zhang J
    . Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. J Pediatr Gastroenterol Nutr 2011; 53: 401–403.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Strugala V,
    2. Dettmar PW,
    3. Bardhan KD, et al.
    Optimisation of the Peptest diagnostic test for detection of GORD using pepsin as a marker: an ideal primary care tool. Gut 2015; 64: Suppl. 1, A492–A493.
    OpenUrlCrossRef
  10. ↵
    1. Faruqi S,
    2. Molyneux ID,
    3. Fathi H, et al.
    Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology 2011; 16: 1150–1156.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Morice AH,
    2. Kastelik JA
    . Cough. 1: Chronic cough in adults. Thorax 2003; 58: 901–907.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 47 Issue 1 Table of Contents
European Respiratory Journal: 47 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of pepsin in sputum: a rapid and objective measure of airways reflux
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Detection of pepsin in sputum: a rapid and objective measure of airways reflux
Vicki Strugala, Andrew D. Woodcock, Peter W. Dettmar, Shoaib Faruqi, Alyn H. Morice
European Respiratory Journal Jan 2016, 47 (1) 339-341; DOI: 10.1183/13993003.00827-2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Detection of pepsin in sputum: a rapid and objective measure of airways reflux
Vicki Strugala, Andrew D. Woodcock, Peter W. Dettmar, Shoaib Faruqi, Alyn H. Morice
European Respiratory Journal Jan 2016, 47 (1) 339-341; DOI: 10.1183/13993003.00827-2015
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Acute lung injury and critical care
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society